NCT02176668

The Exploration for Pharmacodynamics and Pharmacokinetics of YH4808 New Formulation in Healthy Subjects

A Randomized, Open-label, Multiple-dose, Partial Crossover Study to Explore the Pharmacokinetics and the Pharmacodynamics of YH4808 New Formulation in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 82 (actual)
• Sponsor: Yuhan Corporation · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The objective of this clinical trial is to explore pharmacodynamics and pharmacokinetics of YH4808 New Formulation in healthy volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	YH4808 NF 100	The number of times : multiple-dose Rout : oral administration
DRUG	YH4808 OF 200	The number of times : multiple-dose Rout : oral administration
DRUG	YH4808 NF 200	The number of times : multiple-dose Rout : oral administration
DRUG	YH4808 NF 400	The number of times : multiple-dose Rout : oral administration

Timeline

• Start date: 2014-06-01
• Primary completion: 2014-11-01
• Completion: 2014-11-01
• First posted: 2014-06-27
• Last updated: 2022-01-13

Locations

1 site across 1 country: South Korea